Lee Banghyun, Chang Suk-Joon, Kwon Byung Su, Son Joo-Hyuk, Lim Myong Cheol, Kim Yun Hwan, Lee Shin-Wha, Choi Chel Hun, Eoh Kyung Jin, Lee Jung-Yun, Lee Yoo-Young, Suh Dong Hoon, Kim Yong Beom
Department of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
J Gynecol Oncol. 2025 Jan;36(1):e69. doi: 10.3802/jgo.2025.36.e69.
We updated the Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of ovarian cancer as version 5.1. The ovarian cancer guideline team of the KSGO published announced the fifth version (version 5.0) of its clinical practice guidelines for the management of ovarian cancer in December 2023. In version 5.0, the selection of the key questions and the systematic reviews were based on the data available up to December 2022. Therefore, we updated the guidelines version 5.0 with newly accumulated clinical data and added 5 new key questions reflecting the latest insights in the field of ovarian cancer between 2023 and 2024. For each question, recommendation was provided together with corresponding level of evidence and grade of recommendation, all established through expert consensus.
我们将韩国妇科肿瘤学会(KSGO)卵巢癌管理实践指南更新至第5.1版。KSGO的卵巢癌指南团队于2023年12月发布了其卵巢癌管理临床实践指南的第五版(第5.0版)。在第5.0版中,关键问题的选择和系统评价基于截至2022年12月的可用数据。因此,我们用新积累的临床数据更新了第5.0版指南,并增加了5个新的关键问题,以反映2023年至2024年卵巢癌领域的最新见解。对于每个问题,都通过专家共识确定了相应的证据水平和推荐等级,并给出了推荐意见。